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Abstract
In vitro studies with particles are a major staple of particle toxicology, generally used to investigate
mechanisms and better understand the molecular events underlying cellular effects. However,
there is ethical and financial pressure in nanotoxicology, the new sub-specialty of particle
toxicology, to avoid using animals. Therefore an increasing amount of studies are being published
using in vitro approaches and such studies require careful interpretation. We point out here that
3 different conventional pathogenic particle types, PM10, asbestos and quartz, which cause diverse
pathological effects, have been reported to cause very similar oxidative stress effects in cells in
culture. We discuss the likely explanation and implications of this apparent paradox, and its
relevance for testing in nanotoxicology.
The nanoparticle testing problem
It is well-recognised that nanoparticles pose a problem for
toxicological testing. Nanoparticles represent a broad
class of materials that have come under ever greater scru-
tiny, yet there is little generic evidence on which end-
points to choose to predict potential pathogenicity.
Nanoparticles may cause effects like 'conventional parti-
cles' but to a greater degree because of their greater surface
area per unit mass. In addition, they may translocate to
the blood or brain and cause other effects. Nanoparticles
come in an array of compositions, sizes, shapes and with
modified surfaces, all of which could alter toxicity. The
sheer number of variants that need testing has stimulated
a move towards the idea that in vitro testing might provide
an answer to the otherwise large scale animal testing, that
is both expensive and time consuming. Indeed, Nel et al.
[1] have proposed that generation of reactive species and
induction of oxidant stress may form the basis for devel-
opment of in vitro screening methodology. In contrast,
Oberdorster et al. [2] summarized the views of a panel of
nano scientists which placed in vivo studies as primary to
the evaluation of potential health hazard of nanoparticles.
We point out here the potential dangers of exclusive use
of an in vitro screening approach in view of experience
with other particles, suggesting that particles can cause a
rather narrow range of effects on cells in culture which
does not reflect the range of different pathogenic effects
they cause in vivo. This is likely in large part due to the
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issue of translocation and toxicokinetics, which is one of
the most under-researched areas in nanoparticle toxicol-
ogy, as well as for conventional particle toxicology.
Diverse effects of different particles in causing 
disease
It is an apparent paradox that exposure to different kinds
of particles causes a range of different adverse effects
whilst, in vitro at the cellular/molecular level, they have
been found to influence similar pathways and mecha-
nisms, mostly based around oxidative stress. The particles
under consideration here are asbestos, quartz and PM10
and the different diseases they are associated with are indi-
cated in Table 1. As is evident from Table 1, the different
particle types cause different types of pathological effects
despite their deposition in the same target tissue, namely
the airspaces of the lung. Protracted exposure to the differ-
ent particle types results in quite different types of patho-
logical response.
Similar effects of particles in vitro
Numerous in vitro studies indicate that asbestos, quartz
and PM10 have similar activities in cells in vitro – via oxi-
dative stress, activation of NF-κB, pro-inflammatory
effects and oxidative adduct formation (Table 2) [3-24].
We submit that this paradox, i.e. the mismatch between
the similarities in effect seen in vitro and the differences in
disease seen in vivo, poses a threat to the utility of in vitro
nanotoxicology.
In addition, there are other examples where in vitro testing
has been shown to misclassify health hazard. The first
would be glass fibres. Glass fibres have been reported to
be positive in cell testing studies: generating reactive oxy-
gen species, causing oxidant stress, causing DNA damage,
inducing chromosomal aberrations, causing multinuclear
formation, and inducing cell transformation [25]. How-
ever, due to lack of biopersistence, glass fibres have been
reported to exhibit a low pathogenic potential in animal
models. A similar false positive in vitro result has been
reported for kaolin, being as cytotoxic as quartz in cell
studies but exhibiting substantially lower fibrogenicity in
exposed workers [26]. Lastly, a false negative has been
reported for purified single-walled carbon nanotubes,
which do not generate oxidant production or induce
extensive toxicity in cultured macrophages but result in
progressive interstitial fibrosis in mice exposed by pharyn-
geal aspiration or inhalation [27,28].
Fibrosis
Exposure to all 3 particle types discussed in table 1 causes
fibrosis, associated with accumulation of connective tis-
sue cells and their products. At the cellular level, exposure
to these particles is associated with oxidant production,
activation of macrophages, sustained release of inflamma-
tory mediators and growth factors, and activation of extra-
cellular matrix production by fibroblasts. There are,
however, differences in the nature and site of the fibrosis
with the different particles. Asbestos causes predomi-
nantly an interstitial fibrosis in the lung parenchyma and
small airways fibrosis [29]. Pleural plaques are also
fibrotic lesions composed almost entirely of collagen,
which occur on the parietal pleura in asbestos-exposed
individuals [29]. In contrast, quartz is best-known for its
association with nodular fibrosis (silicosis) of the lung
parenchyma. Silica may also cause small airways fibrosis
and pleural fibrosis but it is not characterized by pleural
plaques. The association of PM10 with COPD in chronic
exposure studies and a pathology study by Churg et al.
[30] strongly implicate PM10 in causing airway fibrosis. It
is not immediately clear why PM should cause airway
fibrosis, yet not interstitial or nodular fibrosis, except per-
haps that the severity of the inflammation caused by
PM10 in a low exposure environmental situation is much
less than that caused by quartz and asbestos in a high
exposure occupational setting. Cigarette smoke does not
cause nodular parenchyma fibrosis but does cause inter-
stitial fibrosis [31]. Intrinsic differences in the shape, sur-
face activity and composition of asbestos, quartz and
PM10 might also explain differences in pathogenicity. Dif-
ferences in site of deposition do not offer an explanation,
as respiratory zone deposition can occur with quartz or
asbestos and for the fine particles in PM and cigarette
smoke [32]. The antioxidant defences in the parenchyma
Table 1: Particle-specific adverse health effects of the 3 particle types under consideration.
Adverse effects
Particle Pulmonary Extra-pulmonary
Asbestos Interstitial fibrosis, bronchogenic carcinoma, pleural mesothelioma, pleural 
fibrosis, pleural plaques
Peritoneal mesothelioma, Autoimmune disease
Quartz Nodular fibrosis, small airways disease, bronchogenic carcinoma, pleural 
fibrosis
Autoimmune disease
PM10 Increased lung cancer risk Exacerbations of COPD, Development of COPD 
Exacerbations of asthma
Deaths and hospitalisations for cardiovascular disease,Particle and Fibre Toxicology 2009, 6:13 http://www.particleandfibretoxicology.com/content/6/1/13
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may be more effective against PM than quartz or asbestos,
since quartz or asbestos act via direct membrane/particle
interactions as well as oxidative stress. The high particle
numbers in the ultrafine fraction of PM10 may also lead to
more interaction with the pulmonary epithelium in the
case of PM, which may result in more epithelial injury or
interstitialisation in the case of the latter, both of which
could culminate in fibrosis.
Bronchogenic carcinoma
All 3 of the particle types addressed here have been asso-
ciated with bronchogenic carcinoma (lung cancer). This is
consistent with the airway epithelium as a primary site of
deposition and therefore of highest dose. There could be
differences in the mechanism of cancer, with the 3 particle
types. Asbestos and quartz are essentially insoluble and so
there are no readily identifiable lipophilic components
that could enter the cells and form adducts with the epi-
thelial cell DNA. Both asbestos [33] and quartz [34] can
contain transition metals that could redox cycle and pro-
duce hydroxyl radicals which can form oxidative adducts
like 8 hydroxy deoxyguanosine and activate signalling
pathways which alter the balance between proliferation
and apoptosis [35-37]. PM10, by contrast contains com-
bustion-derived nanoparticles (soot) that contain PAHs
along with other organics derived from fuel and its com-
bustion. These have the potential to diffuse from the par-
ticle surface into cells and cause bulky DNA adducts.
Cardiovascular effects
This is seen only with PM10 and seems a special case of
effects distal to the lungs. The most likely explanation is
that PM10 exposure, unlike asbestos and quartz exposures,
which occur in a workplace, is the only particle exposure
that occurs in susceptible people with cv disease. In
patients with severe cardiovascular disease, even a mild
systemic oxidative stress or inflammatory effects arising in
the lung can impact the cv system [38] and precipitate an
acute coronary syndrome. This is supported by studies
demonstrating clear adverse effects of acute diesel particle
exposure on the endothelium [39] and on ischaemia in
the ventricular myocardium [40]. In addition, pulmonary
exposure to residual oil fly ash, a component of PM, has
been shown to augment adhesion of PMN to systemic
microvessels, induce ROS generation in these vessels, and
decrease the ability of these microvessels to respond to
dilators [41]. Additionally, the combustion-derived NP
particles contained in PM10 may be able to enter the circu-
lation, especially in compromised individuals, and
directly adversely affect the endothelium/plaques [42].
Pleural and peritoneal effects
Pleural mesothelioma Mesothelioma is virtually unique
to asbestos exposure, not being caused by any of the other
particles. The target cell for mesothelioma is the mesothe-
lium of the pleura or the peritoneum. It seems likely that
asbestos fibres need to translocate to the pleural tissue to
have this transforming effect and of course peripheral
alveoli lie sub-pleurally and so any fibres that reach these
peripheral alveoli and interstitialise, are close to the mes-
othelium. The pleura is 'reactive' to inflammation in the
lungs [43] and the mesothelium undergoes proliferation
when there is inflammation in the lung tissue [44].
Inflammation can be detected in the pleural space after
lung exposure [45] to asbestos, and oxidative burst from
the inflammatory leukocytes could be involved in produc-
ing mutation-forming oxidative adducts in the mesothe-
lium but this has never been investigated.
Peritoneal mesothelioma This is an highly unusual
tumour that, like its partner pleural mesothelioma, is only
found with asbestos exposure. Since no other lung expo-
sure, or lung disease, causes such a carcinogenic effect at a
distal site, this argues for translocation of asbestos fibres
to the peritoneal cavity. Other arguments, that oxidative
stress or growth factor release from the lung reaching a
sensitive site in the peritoneal mesothelium, are unlikely
to be unique for asbestos alone.
Table 2: Studies showing significant effects of the different particle types on inflammatory, genotoxic and oxidative stress endpoints in 
vitro
Endpoint
Particle Oxidative 
stress
NF-κB 
activation
AP-1 
Activation
Chemokine 
production 
epithelial cells
TNFα 
production 
macs
Growth 
factor 
production
Direct 
genotox-
icity
Apoptosis
Asbestos [21] [4] [23] [16] [8] [14] fibroblasts [15] [3]
Quartz [9] [17] [18] [20] [6] [24] epithelial 
cells
[35] [12]
PM10 [19] [13] [22] [65] [5] [7] epithelial 
cells
[11] [10]Particle and Fibre Toxicology 2009, 6:13 http://www.particleandfibretoxicology.com/content/6/1/13
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Pleural fibrosis Both asbestos and quartz cause pleural
fibrosis but PM10 does not. Quartz is not, however, con-
sidered to be especially tropic for the pleura and so this
may be a result of reactive changes due to high levels of
growth factors produced locally in the peripheral paren-
chyma. PM10 does not cause pleural fibrosis and this is
consistent with the relative paucity of impact that PM
shows for the parenchyma, given the close association
between the peripheral alveoli and the pleura.
Pleural plaques Only asbestos causes pleural plaques, thin
plaques of acellular collagen on the parietal pleural sur-
face. These are likely a reflection of translocation and the
lymphatic, or other, delivery of fibres to the pleural space
and the failure of longer fibres to be cleared via the sto-
mata in the parietal pleura, the normal site for egress of
lymph from the pleural space. Accumulation at these exit
points of fibres on the pleura is likely to upset the normal
serosal fibrinogenesis balance [46] allowing for a fibri-
nous exudates to form a scaffold for fibrosis. Alternatively,
the presence of fibres on the mesothelium at the stomatal
openings could set up a localised inflammatory response
that is further 'irritated' by breath movements and the fric-
tion of the movement of the pleural surfaces over one
another with maximal contact at the raised areas of the
ribs. These events may combine to produce the character-
istic highly localised fibrotic lesions of pleural plaque
overlying the ribs.
COPD
COPD is a complex syndrome of two important pulmo-
nary diseases-bronchitis and emphysema – that combine
to produce airway narrowing. Although classically it is
caused by cigarette smoking, the new definition includes
gases and dusts as causative agents [47]. Airflow limita-
tion is the characteristic manifestation of COPD, docu-
mented as a decline in FEV1. However there is another
hallmark of the disease, namely, exacerbation. This is
defined as a sudden worsening of the condition, often
necessitating hospitalisation. PM10 has been implicated in
causing one aspect of COPD – small airways fibrosis [30]
and in causing exacerbations of COPD [48]. In one study,
autopsy lungs from age-matched non-smoking females
with no history of working in dusty occupations from a
high PM10 pollution area Mexico City were compared
with lungs from a similar population from low PM10 area
– Vancouver [30]. Using morphometric techniques, con-
siderable fibrosis was detected in the small airways of the
Mexico City dwellers but very little of this type of pathol-
ogy was seen in the Vancouver dwellers. This is evidence
that PM10 causes one aspect of COPD, namely the fibrotic
thickening of the small airways that contributes to airways
obstruction. There are many time-series studies demon-
strating that increases in PM10 cause exacerbations of
COPD in the following hours [49]. There is no evidence
that asbestos or quartz cause development of classical
COPD (emphysema plus bronchitis with exacerbations)
nor that either of these mineral particles causes exacerba-
tion in existing COPD patients.
Asthma
Neither quartz, asbestos nor PM10  appear to 'cause'
asthma in that there is no greater incidence of asthma
amongst either workers or the general populations
exposed to these particles. Increases in PM10 are, however,
associated with increases in exacerbations of asthma in
the hours following increased ambient PM exposure. The
'healthy worker effect' may explain this, in that no indi-
vidual with airflow limitation would work in a dusty trade
as they may anticipate or actually experience additional
respiratory compromise from the dust exposure. In either
case, they are unlikely to remain employed in such an
industry and will seek alternative employment. This is
not, of course, the case for PM10, where everyone, includ-
ing asthmatics, experiences exposure with no choice in the
matter.
Extra-pulmonary effects
Autoimmune disease Autoimmune disease is a common
sequel of chronic inflammatory diseases [50,51]. It is seen
in quartz and asbestos-exposed individuals [52] and may
be a result of the severity of the inflammation seen with
occupational exposure to quartz and asbestos. Lack of
autoimmunity with PM10 exposure may reflect the rela-
tively mild inflammation seen with PM10, supported by
studies with concentrated ambient particles (CAPs) where
only mild inflammation is seen even with CAPs at tens of
times the ambient level [53].
Cardiovascular deaths and hospitalisations Exposure to
PM10 in both chronic and short-term studies is associated
with deaths and hospitalisations for cardiovascular causes
[40,54]. The impact of particle inhalation on athero-
thrombosis, the principal cause of cardiovascular morbid-
ity and mortality, is not well understood but there are a
number of hypotheses. Pulmonary inflammation may be
able to influence events in the atherosclerotic lesions in
the vascular wall, which are also inflammation-driven
[55]. Certainly acute effects such as endothelial dysfunc-
tion and ventricular ischaemia are pronounced in the
short-term after exposure to diluted diesel exhaust in
chamber studies [39,56]. Animal studies suggest that
inflammation caused by pulmonary deposition of diesel
particles can enhance the thrombogenicity of the blood
[57]. Nurkiewicz et al. [41] have also reported that pulmo-
nary exposure to residual oil fly ash causes PMN adher-
ence and ROS production at systemic microvessels. In
addition, nanoparticles in PM10 may be able to enter the
circulation and directly affect the atherosclerotic plaque or
the overlying endothelium [58].Particle and Fibre Toxicology 2009, 6:13 http://www.particleandfibretoxicology.com/content/6/1/13
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Similar effects of the different particles in vitro
It is clear from the above that the 3 different particle types
cause a spectrum of adverse effects both in the lungs and
at extra-pulmonary sites. This contrasts with the distinct
similarities in the nature of the responses seen in in vitro
studies with the same 3 particle types. This is shown in
Table 2. All 3 particle types, when added to cells in culture,
show abilities to cause oxidative stress, activation of
redox-sensitive transcription factors, cytokine and chem-
okine production, growth factor release, and direct geno-
toxicity.
Oxidative stress is a strong over-arching theme in the cel-
lular effects of particles. In general, the responses to parti-
cles can be understood as responses to oxidative stress.
Most pathogenic particles appear to cause oxidative stress
in target cells. The ubiquitousness of this effect is striking
and may reflect some fundamental response of cells to
foreign surfaces inside the cell as well as the obvious
redox-cycling of some particle components like organics
[59] and transition metals [60]. Oxidative stress is a sig-
nalling system in cells that leads to gene expression [61].
Increasing levels of oxidative stress inside cells caused by
particles may result in graded response from anti-oxidant
defence induction via NF-κB and AP-1, through pro-
inflammatory signalling via the same transcription factors
to induction of apoptosis [1]. Therefore it is something of
a self-fulfilling prophecy that adding particle to cells will
cause oxidative stress if the dose is high enough, and that
if there is oxidative stress there will be NF-κB and AP-1
activation. The activation of the transcription factors is
tightly related to redox balance in the cell. There may be
exceptions, however, and in our hands quartz and raw car-
bon nanotubes (metal contaminated) cause the same
degree of glutathione depletion but only quartz causes
NF-κB activation. Therefore particle-derived oxidative
stress alone may not be sufficient but may often be accom-
panied by one or more other signals to the cells from the
particles for transcription. It has been proposed that the
more pathogenic the particle, the more it causes oxidative
stress [1]. However, this relationship does not hold for
purified (low metal) single-walled carbon nanotubes.
Although raw single-walled carbon nanotubes have been
shown to be toxic to bronchial epithelial cells in vitro,
ROS generation and oxidant damage appear dependent
on the presence of contaminating iron [62]. Indeed, in
vitro exposure of macrophages to purified single-walled
carbon nanotubes failed to induce ROS production or
stimulate production of inflammatory cytokines [27].
Release of chemokines, cytokines and growth factors can
be grouped together as they are all secretions from cells,
normally leukocytes, that induce inflammation or mesen-
chymal cell activation or proliferation. Once again all of
the particles considered here when added to one target cell
or another stimulate the gene expression and release of
these mediators. Macrophage-derived cytokines, such as
TNFα, act on epithelial cells to enhance their chemokine
response to particles [63,64]. Many cytokines and chem-
okines, such as IL-8 [65,66] and TNFα [67] have NF-κB
motifs in their promoter and are oxidative stress-respon-
sive and so their activation is to be anticipated, if oxidative
stress is present.
Genotoxicity and apoptosis are linked together because of
the relationship between genotoxicity and the induction
of apoptosis [68]; again there is a common role for oxida-
tive stress in both processes. However, purified single-
walled carbon nanotubes appear to be an exception to this
rule, since inhalation exposure in mice caused k-ras gene
mutation without persistent oxidant stress [28].
Conclusion and relevance for predictive 
toxicology of nanoparticles
Taken together, these in vitro data tell us that oxidative
stress is a central tenet of the current hypothesis on the
action of particles at the cellular level. This is in keeping
with understood actions of a large number of chemicals,
such as metals, organics, etc., that also act by causing oxi-
dative stress in various target tissues and organs [69-75]
(Figure 1). This suggests that the information that is gar-
nered from a study that demonstrates that a particle can
cause oxidative stress in vitro may be of highly questiona-
ble value. The real question is whether different particles
have different abilities to deliver oxidative stress and pos-
sibly the nature of the oxidative stress or its site of delivery
both inside the cell and in target tissues distant to the air-
space surface on which the particle deposits. The latter
implies a need for toxicokinetics to understand plausible
dose in any target tissue. Such toxicokinetics as has been
carried out on particles suggests, for example, that particle
size is related to translocation, and that larger particles do
not on the whole translocate to any appreciable degree,
except for asbestos. This seems evident from Figure 1,
where asbestos seems to be able to translocate most effi-
ciently and has the smallest or at least thinnest particles.
At the moment the particle toxicology world is dominated
by the issue of nanotoxicology and the effects of nanopar-
ticles. The experience with combustion-derived nanopar-
ticles and PM10  and some studies with manufactured
nanoparticles suggest that there could be risk from the
development and use of manufactured nanoparticles.
There are many new particle types that await testing, but
there is no great appetite for animal testing. Thus, there is
a perceived need for in vitro testing that can predict the
hazard. It might be tempting to carry out in vitro toxicol-
ogy alone, and it might not be surprising to find that some
of these particles cause oxidative stress and NF-κB activa-
tion etc. [1]. However, purified single-walled carbon nan-Particle and Fibre Toxicology 2009, 6:13 http://www.particleandfibretoxicology.com/content/6/1/13
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otubes appear to be an exception to this general rule [27].
In this case, direct action on lung fibroblasts (increase pro-
liferation, augmentation of collagen production, and
induction of cytokine message) rather than oxidant stress
may explain the in vivo response (interstitial fibrosis) to
single-walled carbon nanotubes [76,77]. The content of
the present paper, however, suggests that great care should
be taken in interpreting in vitro data. A particle that causes
oxidative stress to cells in culture could, in theory, behave
like quartz, asbestos or PM10, and it would not be evident
which of these it would behave like, from the in vitro data.
Short of waiting for the diseases themselves to develop,
what can we do to assist in bridging the gap between in
vitro and disease prediction, Dosimetry data is one way
forward but this is notoriously difficult and there is no
mass balance toxicokinetic data available for any particle.
It seems unlikely that PBPK modelling can adequately
predict nanoparticle dosimetry, although there are ongo-
ing efforts. Toxicokinetics is difficult and expensive but
offers the only way forward in order to put in vitro studies
on a relevant and plausible footing with regard to dose to
use, target cells to study, and ultimately, the usefulness in
hazard identification.
None of the above is meant to say that in vitro toxicology
isn't valuable for understanding mechanisms. It is abso-
lutely vital for this purpose and has formed the backbone
of the authors' research. However, in vitro research cannot
replace some aspects of animal testing, and there is need
for investment in good nanotoxicology research across all
aspects of the discipline to gain the advances in under-
standing that are needed.
In addition to providing toxicokinetics and dosimetric
data, in vivo testing of nanoparticles also remains impor-
tant because of the possibility of picking up a novel
pathology or target tissue. In vivo testing also sidesteps the
difficulty in linking "generic" cellular responses to differ-
ent pathologies but is also needed because no, or only
poor, in vitro alternatives currently exist for many "sys-
temic" responses such as cardiovascular responses,
immune responses and syndromes such as COPD. We
need to continue to invest in in vivo testing because many
diseases linked to nanoparticles are systemic in nature. In
addition the distribution of nanoparticles in different
organs and tissue is poorly studied. At the same time, tox-
icologists need both in vivo and in vitro models to study
the pathogenesis of these diseases and the behaviour of
nanoparticles at all levels, organismal to sub-cellular.
Only limited progress has been made in developing in
vitro models to study the distribution and translocation of
nanoparticles across the different barriers. More effort is
urgently needed develop more specific in vitro models
that will enable us to understand systemic effects of nano-
materials.
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